Health

Innovative heart condition drug recommended for NHS patients



A

first-of-its-kind treatment targeting a chronic heart disease could offer a “greater hope” to thousands of people living with the condition.

The National Institute for Health and Care Excellence (Nice) has approved the use of mavacamten in draft guidance to the NHS.



READ SOURCE

This website uses cookies. By continuing to use this site, you accept our use of cookies.